ASC infusion also promoted significant reductions in the peritoneal gene and protein expressions of IL-1β, TNF-α, and IL-6 in the ASC-treated CKD+PF animals, compared to untreated CKD+PF rats. This evidence concerns the gene IL6 and chronic kidney disease.